Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Expert Rev Pharmacoecon Outcomes Res ; 24(8): 943-952, 2024 Oct.
Article in English | MEDLINE | ID: mdl-38832499

ABSTRACT

INTRODUCTION: Considering the prospects of increased prevalence and disability due to neck and low back pain, it is relevant to investigate the care processes adopted, to assist future public policies and decision-making for a better allocation of resources. Objective: the aim of this study was to estimate the costs arising from inpatient and outpatient care of individuals with Neck Pain (NP) and Low Back Pain (LBP) in Brazil, between 2010 and 2019. METHODS: This is a cost-of-illness study from the perspective of the Brazilian public health system, based on health conditions with high prevalence (neck and low back pain). Data were presented descriptively using absolute and relative values. RESULTS: Between 2010 and 2019, the health system spent more than $600 million (R$ 2.3 billion) to treat NP and LBP in adults, and LBP accounted for most of the expenses. Female had higher absolute expenses in inpatient care and in the outpatient system. CONCLUSION: Our study showed that the costs with NP and LBP in Brazil were considerable. Female patients had higher outpatient costs and male patients had higher hospitalization costs. Healthcare expenses were concentrated for individuals between 34 and 63 years of age.


This study focused on understanding how much it cost to treat neck pain (NP) and low back pain (LBP) in Brazil between 2010 and 2019, from the point of view of the public health system (i.e. Unified Health System ­ SUS). The idea was to find out how much money was spent and where. It turned out that the SUS spent, in total, more than US$600 million (R$2.3 billion) with LBP responsible for most of these expenses. Furthermore, we noted that women had higher outpatient care costs, while men had higher hospitalization costs. Those costs were more concentrated in people aged between 34 and 63 years.


Subject(s)
Ambulatory Care , Cost of Illness , Health Care Costs , Hospitalization , Low Back Pain , Neck Pain , Humans , Brazil , Low Back Pain/economics , Low Back Pain/therapy , Female , Male , Adult , Middle Aged , Neck Pain/therapy , Neck Pain/economics , Health Care Costs/statistics & numerical data , Hospitalization/economics , Hospitalization/statistics & numerical data , Ambulatory Care/economics , Prevalence , Young Adult , Public Health/economics , Aged , Sex Factors , Adolescent , Age Factors
2.
Pediatr Transplant ; 28(3): e14713, 2024 May.
Article in English | MEDLINE | ID: mdl-38553819

ABSTRACT

BACKGROUND: This study aimed to compare the efficacy and safety of basiliximab (BAS) versus a single dose of anti-thymocyte globulin (r-ATG) induction therapy in pediatric kidney transplant recipients (KTRs). METHODS: This single-center retrospective comparative cohort study included all pediatric KTRs from May 2013 to April 2018 and followed up to 12 months. In the first period, all recipients received BAS, while from May 2016, a single 3 mg/kg dose of r-ATG was instituted. Maintenance therapy consisted of a calcineurin inhibitor plus prednisone plus azathioprine or mycophenolate. RESULTS: A total of 227 patients were included (BAS, n = 113; r-ATG, n = 114). The main combination of immunosuppressive drugs was tacrolimus, prednisone, and azathioprine in both groups (87% vs. 88%, p = .718). Patients receiving r-ATG showed superior survival-free of the composite endpoint (acute rejection, graft loss, or death; 76% vs. 61%, p = .003; HR 2.08, 1.29-3.34, p = .003) and lower incidence of biopsy-proven acute rejection (10% vs. 21%, p = .015). There was no difference in the overall incidence of CMV infection (33% vs. 37%, p = .457), PTLD (1% vs. 3%, p = .309), 30-day hospital readmissions (24% vs. 23%, p = .847), and kidney function at 12 months (86 ± 29 vs. 84 ± 30 mL/min/1.73m2, p = .614). CONCLUSIONS: These data suggest that induction therapy with a single 3 mg/kg dose of r-ATG is associated with higher efficacy for preventing acute rejection and similar safety profile compared to BAS.


Subject(s)
Antilymphocyte Serum , Kidney Transplantation , Humans , Child , Basiliximab/therapeutic use , Antilymphocyte Serum/therapeutic use , Antibodies, Monoclonal/therapeutic use , Prednisone/therapeutic use , Retrospective Studies , Cohort Studies , Azathioprine , Induction Chemotherapy , Graft Rejection/prevention & control , Graft Rejection/epidemiology , Immunosuppressive Agents/therapeutic use , Recombinant Fusion Proteins/therapeutic use , Transplant Recipients
3.
Braz J Phys Ther ; 27(5): 100553, 2023.
Article in English | MEDLINE | ID: mdl-37862916

ABSTRACT

BACKGROUND: Understanding the care pathway is essential to identify how to effectively treat spinal disorders. However, there is no specific data on the pathway of these individuals in the Health Care Networks (HCN) in Brazil. OBJECTIVE: To investigate the pathway of individuals with non-specific spinal disorders (NSD) in the HCN in the Federal District, Brazil, and verify the interventions adopted, and to test whether sociodemographic and clinical variables predict the number of imaging tests, prescribed medication, and the first HCN access. METHODS: Retrospective study that analysed electronic records of 327 individuals with NSD between 2012 and 2018. Generalized linear models estimated the association between sociodemographic and clinical data and number of drugs prescribed and imaging tests requested. Multinomial logistic regression estimated the association between clinical and demographic variables and setting of first access. RESULTS: The median age was 57 years, and 75.5% were women. Emergency Department (ED) was the most accessed setting (43.7%), and back pain was the most prevalent condition (84.5%). Most individuals underwent imaging tests (60%) and drug prescriptions (86%). Physical exercises were prescribed to 13%, and 55% were referred to physical therapy. Women were more likely to first access the ED. CONCLUSION: The ED was the most used setting by people with NSD. Few participants received exercise prescriptions and half were referred to physical therapists. Individuals who used outpatient clinics and primary care received less drug prescriptions, and women were more likely to first access the ED. Increasing age was associated with greater chance of first accessing Outpatient Clinics.


Subject(s)
Critical Pathways , Delivery of Health Care , Humans , Female , Middle Aged , Male , Retrospective Studies , Brazil
5.
Cien Saude Colet ; 28(1): 231-242, 2023 Jan.
Article in Portuguese, English | MEDLINE | ID: mdl-36629568

ABSTRACT

Aging has imposed changes in the epidemiological profile and an increase in the prevalence of chronic non-communicable diseases (CNCDs). The aim was to estimate the direct cost related to hospital admissions of elderly people affected by CNCDs (hypertension, heart failure and diabetes mellitus) sensitive to primary care, in a medium-sized hospital, in the period 2015-2019. Secondly, we investigated whether clinical and demographic factors explain the costs and length of stay. The medical records of 165 elderly people were analyzed. We found a predominance of women with a mean age of 76.9 years. The most frequent cause of hospitalization was heart failure (62%), and the average length of stay was 9.5 days, and 16% of hospitalizations corresponded to rehospitalizations. Of these, 81% were caused by complications from the previous hospitalization. The estimated total cost was R$ 3 million. Male patients had a longer hospital stay compared to female patients. Hypertension and the total number of procedures were significant predictors of cost and length of stay. We found that in 5 years, the costs of hospital admissions for conditions sensitive to primary care in the elderly are considerable, indicating the relevance of investments in primary care.


O envelhecimento tem imposto mudanças epidemiológicas e aumento na prevalência de doenças crônicas não-transmissíveis (DCNT). O objetivo foi estimar o custo direto relacionado às internações hospitalares de idosos acometidos por DCNT (hipertensão arterial, insuficiência cardíaca e diabetes mellitus) sensíveis à atenção primária, em hospital de médio porte, no período de 2015-2019. Secundariamente, investigamos se fatores clínicos e demográficos explicam o custo e tempo de permanência. Foram analisados prontuários de 165 idosos. Verificamos predominância de mulheres com média de idade de 76,9 anos. A causa de internação mais frequente foi insuficiência cardíaca (62%) e o tempo médio de permanência foi de 9,5 dias, e 16% das internações corresponderam a idosos reinternados. Dessas, 81% foram causadas por complicações da internação anterior. O custo total estimado foi de R$ 3 milhões. Pacientes do sexo masculino ficaram mais tempo internados, comparado ao sexo feminino. Hipertensão e o total de exames realizados foram preditores significantes do custo e tempo de permanência. Verificamos que em 5 anos, os custos com internações hospitalares por condições sensíveis à atenção primária em idosos são consideráveis, indicando a relevância de investimentos na atenção primária.


Subject(s)
Heart Failure , Hospitalization , Hypertension , Noncommunicable Diseases , Aged , Female , Humans , Male , Health Care Costs , Heart Failure/epidemiology , Hospitals , Hypertension/epidemiology , Noncommunicable Diseases/epidemiology , Noncommunicable Diseases/therapy , Primary Health Care
6.
Ciênc. Saúde Colet. (Impr.) ; 28(1): 231-242, jan. 2023. tab, graf
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1421128

ABSTRACT

Resumo O envelhecimento tem imposto mudanças epidemiológicas e aumento na prevalência de doenças crônicas não-transmissíveis (DCNT). O objetivo foi estimar o custo direto relacionado às internações hospitalares de idosos acometidos por DCNT (hipertensão arterial, insuficiência cardíaca e diabetes mellitus) sensíveis à atenção primária, em hospital de médio porte, no período de 2015-2019. Secundariamente, investigamos se fatores clínicos e demográficos explicam o custo e tempo de permanência. Foram analisados prontuários de 165 idosos. Verificamos predominância de mulheres com média de idade de 76,9 anos. A causa de internação mais frequente foi insuficiência cardíaca (62%) e o tempo médio de permanência foi de 9,5 dias, e 16% das internações corresponderam a idosos reinternados. Dessas, 81% foram causadas por complicações da internação anterior. O custo total estimado foi de R$ 3 milhões. Pacientes do sexo masculino ficaram mais tempo internados, comparado ao sexo feminino. Hipertensão e o total de exames realizados foram preditores significantes do custo e tempo de permanência. Verificamos que em 5 anos, os custos com internações hospitalares por condições sensíveis à atenção primária em idosos são consideráveis, indicando a relevância de investimentos na atenção primária.


Abstract Aging has imposed changes in the epidemiological profile and an increase in the prevalence of chronic non-communicable diseases (CNCDs). The aim was to estimate the direct cost related to hospital admissions of elderly people affected by CNCDs (hypertension, heart failure and diabetes mellitus) sensitive to primary care, in a medium-sized hospital, in the period 2015-2019. Secondly, we investigated whether clinical and demographic factors explain the costs and length of stay. The medical records of 165 elderly people were analyzed. We found a predominance of women with a mean age of 76.9 years. The most frequent cause of hospitalization was heart failure (62%), and the average length of stay was 9.5 days, and 16% of hospitalizations corresponded to rehospitalizations. Of these, 81% were caused by complications from the previous hospitalization. The estimated total cost was R$ 3 million. Male patients had a longer hospital stay compared to female patients. Hypertension and the total number of procedures were significant predictors of cost and length of stay. We found that in 5 years, the costs of hospital admissions for conditions sensitive to primary care in the elderly are considerable, indicating the relevance of investments in primary care.

8.
Transplantation ; 106(2): 381-390, 2022 02 01.
Article in English | MEDLINE | ID: mdl-33988338

ABSTRACT

BACKGROUND: The short-term efficacy and safety of everolimus in combination with tacrolimus have been described in several clinical trials. Yet, detailed long-term data comparing the use of everolimus or mycophenolate in kidney transplant recipients receiving tacrolimus are lacking. METHODS: This is a 5-y follow-up post hoc analysis of a prospective trial including 288 patients who were randomized to receive a single 3-mg/kg dose of rabbit antithymocyte globulin, tacrolimus, everolimus (EVR), and prednisone (rabbit antithymocyte globulin/EVR, n = 85); basiliximab, tacrolimus, everolimus, and prednisone (basiliximab/EVR, n = 102); or basiliximab, tacrolimus, mycophenolate, and prednisone (basiliximab/mycophenolate, n = 101). RESULTS: There were no differences in the incidence of treatment failure (31.8% versus 40.2% versus 34.7%, P = 0.468), de novo donor-specific HLA antibodies (6.5% versus 11.7% versus 4.0%, P = 0.185), patient (92.9% versus 94.1% versus 92.1%, P = 0.854), and death-censored graft (87.1% versus 90.2% versus 85.1%, P = 0.498) survivals. Using a sensitive analysis, the trajectories of estimated glomerular filtration rate were comparable in the intention-to-treat (P = 0.145) and per protocol (P = 0.354) populations. There were no differences in study drug discontinuation rate (22.4% versus 30.4% versus 17.8%, P = 0.103). CONCLUSIONS: In summary, this analysis in a cohort of de novo low/moderate immunologic risk kidney transplant recipients suggests that the use of a single 3 mg/kg rabbit antithymocyte globulin dose followed by EVR combined with reduced tacrolimus concentrations was associated with similar efficacy and renal function compared with the standard of care immunosuppressive regimen.


Subject(s)
Kidney Transplantation , Tacrolimus , Drug Therapy, Combination , Everolimus/adverse effects , Graft Rejection , Graft Survival , Humans , Immunosuppressive Agents/adverse effects , Kidney Transplantation/adverse effects , Mycophenolic Acid/adverse effects , Prospective Studies , Tacrolimus/adverse effects
9.
Pediatr Transplant ; 23(6): e13463, 2019 09.
Article in English | MEDLINE | ID: mdl-31332958

ABSTRACT

The Brazilian collaborative registry for pediatric renal transplantation began in 2004 as a multicenter initiative aimed at analyzing, reporting, and disseminating the results of pediatric renal transplantation in Brazil. Data from all pediatric renal transplants performed from January 2004 to May 2018 at the 13 participating centers were analyzed. A total of 2744 pediatric renal transplants were performed in the thirteen participating centers. The median age at transplantation was 12.2 years, with the majority being male recipients (56%). The main underlying diseases were CAKUT (40.5%) and glomerulopathy (28%). 1981 (72%) of the grafts were from deceased donors (DD). Graft survival at one year (censored by death) was 94% in the live donor group (LD) and 91% in the DD group (log-rank test P < 0.01). The patient's survival at one and 5 years was 97% and 95% for the LD group and 96% and 93% for the DD group (log-rank test P = 0.02). The graft loss rate was 19% (n = 517), more frequently caused by vascular thrombosis (n = 102) and chronic graft nephropathy (n = 90). DD recipients had 1.6 (1.0-2.2) times greater chance of death and 1.5 (1.2-1.8) times greater chance of graft loss compared to LD recipients. The mortality rate was 5.4% (n = 148), mainly due to infection (n = 69) and cardiovascular disease (n = 28). The results of this collaborative pediatric renal transplant record are comparable to other international registries, although we still have a high infection rate as a cause of death.


Subject(s)
Graft Survival , Kidney Diseases/surgery , Kidney Transplantation , Registries , Adolescent , Brazil , Child , Cyclosporine/pharmacology , Female , Follow-Up Studies , Graft Rejection , Humans , International Cooperation , Kidney Diseases/complications , Kidney Failure, Chronic , Living Donors , Male , Postoperative Complications/mortality , Thrombosis/physiopathology , Tissue and Organ Procurement
10.
Periodontia ; 18(3): 57-62, 2008. tab
Article in Portuguese | LILACS, BBO - Dentistry | ID: lil-587901

ABSTRACT

Os profissionais de saúde e instituições assistenciais geralmente priorizam o atendimento às gestantes durante o pré-natal garantindo a elas atenção necessária para que seus filhos nasçam saudáveis. Entretanto, nota-se que as ações são limitadas por não informarem o impacto que a condição periodontal pode ter sobre a prematuridade e o baixo peso ao nascer. Este estudo avaliou a normatização da pastoral da criança e do Sistema Único de Saúde e verificou, por meio de questionário e exame periodontal, gestantes cadastradas na Pastoral da Criança do Município de Pindamonhangaba, interior de São Paulo, quanto à presença da doença periodontal e orientação recebida sobre o risco na gestação. Foi observado que mesmo sendo portadoras de periodontite, havia desconhecimento por parte das gestantes, sobre o risco da doença periodontal na gestação. A gestante merece especial atenção no pré-natal, uma vez que a doença periodontal materna é um fator de risco para o nascimento de bebês prematuros e/ou com baixo peso.


The health professionals and Assistant Institutions usually give priority to attend pregnant during the period previous to birth, securing to pregnant woman necessarily care to her baby be born healthful. However it is noticed that actions or activities are limited and don’t inform the impact of periodontal disease has on the prematurity and the low birth weight. This study evaluated the normative judgment of “Pastoralda Criança” (religion organization that gives children pastoral care and “Sistema Único de Saúde” (public health care, Brazil) and registered by means of questionnaire and evaluation of periodontal condition in pregnant in “Pastoral da Criança” of Pindamonhangaba-SP, Brazil, how much the presence of the periodontal disease and orientation received about the risk of periodontitis in pregnancy. The unfamiliarity was observed, on the part of the pregnant with periodontitis,on the risk of the periodontal disease in the gestation. The pregnant deserves special attention; a time that moderateto severe periodontitis disease is a factor of risk for the birth of premature babies or with low weight.


Subject(s)
Humans , Female , Periodontitis , Pregnancy , Prenatal Care
SELECTION OF CITATIONS
SEARCH DETAIL